High times for cannabis: Epigenetic imprint and its legacy on brain and behavior
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
HIGHLIGHTSLong‐term developmental effects of cannabis largely lack in‐depth scientific data.The epigenome underlies molecular and behavioral effects of cannabinoids.We discuss epigenetic dysregulation by prenatal, adolescent and germline cannabis.Expanding epigenetic knowledge will provide targets for treatment interventions. ABSTRACT Extensive debates continue regarding marijuana (Cannabis spp), the most commonly used illicit substance in many countries worldwide. There has been an exponential increase of cannabis studies over the past two decades but the drug's long‐term effects still lack in‐depth scientific data. The epigenome is a critical molecular machinery with the capacity to maintain persistent alterations of gene expression and behaviors induced by cannabinoids that have been observed across the individual's lifespan and even into the subsequent generation. Though mechanistic investigations regarding the consequences of developmental cannabis exposure remain sparse, human and animal studies have begun to reveal specific epigenetic disruptions in the brain and the periphery. In this article, we focus attention on long‐term disturbances in epigenetic regulation in relation to prenatal, adolescent and parental germline cannabinoid exposure. Expanding knowledge about the protracted molecular memory could help to identify novel targets to develop preventive strategies and treatments for behaviors relevant to neuropsychiatric risks associated with developmental cannabis exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169 · cited 1×
“In a recent systematic study of randomized clinical trials (Whiting et al., 2015) only moderate to low quality evidence supported the beneficial clinical effects of medical cannabinoids.”
BackgroundCannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059 · cited 2×
“…cannabinoid shown to have anti-inflammatory effects, to protect neurons from injury or degeneration, to reduce anxiety, to attenuate drug craving in certain people, and to have antipsychotic properties (Hampson et al., 1998; Hurd et al., 2015; Leweke et al., 2012; Zuardi et al., 1982).”
BackgroundGlass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052 · cited 2×
“CB1Rs are the most-abundant G protein-coupled receptors that are expressed in the adult brain, and they show particularly dense distribution in regions that are involved in reward processing and cognitive functions, such as the ventral pallidum, caudate putamen, nucleus accumbens (NAc), ventral tegmental area, amygdal…”
BackgroundTranscriptional and epigenetic mechanisms of addiction
Robison, A. J., & Nestler, E. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3111 · Cited by 993
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850 · cited 1×
“…cannabinoid shown to have anti-inflammatory effects, to protect neurons from injury or degeneration, to reduce anxiety, to attenuate drug craving in certain people, and to have antipsychotic properties (Hampson et al., 1998; Hurd et al., 2015; Leweke et al., 2012; Zuardi et al., 1982).”
BackgroundUncovering the role of 5-hydroxymethylcytosine in the epigenome
Branco, M. R., Ficz, G., & Reik, W. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3080 · Cited by 766 · cited 1×
“The oxidation of 5mC to 5- hydroxymethylcytosine (5hmC) by ten-eleven translocation (TET) proteins can prevent access to DNMTs and thereby can maintain an unmethylated state of the promoter, facilitating transcriptional activation (Branco et al., 2012).”
BackgroundCrean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31820c23fa · Cited by 732 · cited 1×
“…cognitive deficits, social impairments and subsequent drug addiction (Alegria et al., 2010; Bassir Nia et al., 2016; Charilaou et al., 2017; Crean et al., 2011; Feingold et al., 2017; JutrasAswad et al., 2009; Kedzior and Laeber, 2014; Leweke and Koethe, 2008; Malone et al., 2010; Morris…”
BackgroundFrom the ventral to the dorsal striatum: devolving views of their roles in drug addiction
Everitt, B. J., & Robbins, T. W. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.010 · Cited by 675
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
The Emerging Field of Neuroepigenetics
Sweatt, J. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.023 · Cited by 324 · cited 2×
“Intriguingly, the dynamic control of DNA methylation and demethylation has recently been strongly implicated in the regulation of synaptic plasticity and drug addiction (Feng et al., 2015; Lunnon et al., 2016; Sweatt, 2013, 2016).”
BackgroundMethylomic trajectories across human fetal brain development
Spiers, H., Hannon, E., Schalkwyk, L. C., Smith, R., Wong, C. C. Y., O’Donovan, M. C., Bray, N. J., & Mill, J. (2015) · Genome Research · doi:10.1101/gr.180273.114 · Cited by 287
Nongenetic inheritance and transgenerational epigenetics
Szyf, M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.004 · Cited by 238 · cited 2×
“Interestingly, DNA methylation marks at specific gene loci have been shown to even persist during the maturation of germ cells (Szyf, 2013, 2015) and thus are interesting candidates for the transmission of cannabis effects from parent to child and possibly throughout multiple generations.”
BackgroundAdolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237
Cannabis and psychiatric disorders: it is not only addiction
Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213 · cited 2×
“disturbances associated with cannabis exposure such as psychosis, anxiety, depression, cognitive deficits, social impairments and subsequent drug addiction (Alegria et al., 2010; Bassir Nia et al., 2016; Charilaou et al., 2017; Crean et al., 2011; Feingold et al., 2017; JutrasAswad et al., 2009; Kedzior and Laeber, 20…”
BackgroundCannabis use during adolescent development: Susceptibility to psychiatric illness
Chadwick, B., Miller, M. L., & Hurd, Y. L. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00129 · Cited by 210
Self-citationThe Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models
Rubino, T., & Parolaro, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.024 · Cited by 183 · cited 2×
“Although the evidence is not absolute, an extensive body of literature has begun to specifically link marijuana use by pregnant women and during adolescence with adult mental health disturbances later in life (Barthelemy et al., 2016; Chadwick et al., 2013; Jutras-Aswad et al., 2009; Morris et al., 2011; Rubino and Pa…”
BackgroundBrander, G., Pérez-Vigil, A., Larsson, H., & Mataix-Cols, D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.011 · Cited by 172
Cecil, C. A. M., Walton, E., Smith, R. G., Viding, E., McCrory, E. J., Relton, C. L., Suderman, M., Pingault, J.-B., McArdle, W., Gaunt, T. R., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.247 · Cited by 101 · cited 3×
“More recently, Cecil et al. (Cecil et al., 2016) conducted the first genome-wide, relatively large human study to examine associations between DNA methylation alterations in blood from birth to early childhood and tobacco, cannabis and alcohol use later in adolescence in subjects from the Avon…”
BackgroundMechanisms of transgenerational inheritance of addictive-like behaviors
Vassoler, F. M., & Sadri-Vakili, G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.064 · Cited by 96 · cited 1×
“Several cases of parent-child transmission regarding drugs of abuse have been published, describing both behavioral phenotypes and molecular disturbances in the offspring of parents that were exposed to drugs before mating and conception (reviewed in (Vassoler and Sadri-Vakili, 2014)).”
BackgroundKirschmann, E. K., Pollock, M. W., Nagarajan, V., & Torregrossa, M. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.178 · Cited by 59
Cited by
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects
Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1165-19.2019 · Cited by 218
Self-citationDisentangling the lasting effects of adolescent cannabinoid exposure
Stringfield, S. J., & Torregrossa, M. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110067 · Cited by 32
Szutorisz, H., & Hurd, Y. L. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.018 · Cited by 9
Self-citationValeria, S., Francesco, T., Sonia, A., Laura, V. P., Luca, C., Marcello, S., Roberta, L., Patrizia, P., Arnau, B. G., Roberto, F., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107536 · Cited by 8
Metadata
- Authors
- Szutorisz, H., & Hurd, Y. L.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 85
- Pages
- 93-101
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2614025280
- Cited by
- 131
- References
- 21
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.